Priority Date: 22.06.12 (FR 20120055917)

NOVEL 2,3-DIHYDRO-1H-IMIDAZO{1,2-a}PYRIMIDIN-5-ONE and this1,2,3,4-TETRAHYDROPYRIMIDO{1,2-a}PYRIMIDIN-6-ONE DERIVATIVES COMPRISING A SUBSTITUTED MORPHOLINE, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF

  • Application ID: EP13773341
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1123.74
3 offices
active in Legal Services
no operation time available
2 offices
Technology Company
no operation time available
2 offices
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 22.06.2012 - Priority Date (FR 20120055917)
  • 27.12.2013 - Publication A2 (WO2013190510)
  • 29.04.2015 - Publication A2 (EP2864295)
  • 13.12.2017 - Publication B1 (EP2864295)